VeinWay

Advanced Vein Blockage Crossing Tools

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in November 2020 by Jordan Pollack and Ben Friesem, VeinWay operates with 1–10 employees. The company has secured $7.43 million across four funding rounds from two investors. In September 2023, VeinWay closed an oversubscribed SAFE round.

Business overview

VeinWay is a Health Tech & Life Sciences company focused on developing novel technology for crossing chronically occluded veins. Its core product, Traversa, is designed for venous recanalization, aiming to improve outcomes and facilitate endovascular procedures for the effective treatment of Chronic Venous Occlusions (CVOs). The company serves the healthcare industry, specifically targeting interventional radiologists and vascular surgeons in the medical devices, cardiology, and vascular sectors across Europe and North America.

Strategic signal

In May 2024, the CEO of VeinWay stated that the current year is pivotal for the company. This indicates a period of significant strategic focus and potential for major advancements or market penetration, signaling to investors a critical phase for growth and validation of its venous recanalization technology.

Company Intelligence Q&A

What is VeinWay's primary product?
VeinWay's primary product is Traversa, a dedicated device designed for venous recanalization to improve outcomes and facilitate endovascular procedures for Chronic Venous Occlusions (CVOs).
When was VeinWay founded?
VeinWay was founded in November 2020 as part of the entrepreneur in residence program with the MEDX Xelerator.
Which investors participated in VeinWay's September 2023 SAFE round?
In September 2023, VeinWay closed an oversubscribed SAFE round with participation from Consensus Business Group (CBG).
What was a key development for VeinWay in May 2024?
In May 2024, VeinWay's CEO highlighted the year as pivotal for the company, suggesting significant strategic developments or market milestones are anticipated.
What grant did VeinWay receive in December 2020?
In December 2020, VeinWay received a grant from the Israel Innovation Authority.

External links